- Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay. https://www.nejm.org/doi/10.1056/nejmoa2023184 54 comments science
Linking pages
- How Science in India Became a 'Political Weapon' Under Modi - The New York Times https://www.nytimes.com/2021/09/14/world/asia/india-modi-science-icmr.html 29 comments
- RETRACTED ARTICLE: Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease | Scientific Reports https://www.nature.com/articles/s41598-021-90189-4 17 comments
- Ivermectin--Upon Neutral Ground - by Steven Phillips, MD https://zerospin.substack.com/p/ivermectin-upon-neutral-ground?s=r 5 comments
- The Drug Trial That Could Actually Produce Covid Treatments | WIRED https://www.wired.com/story/the-drug-trial-that-could-actually-produce-covid-treatments 5 comments
- A Large, Simple Trial Leading to Complex Questions | NEJM https://www.nejm.org/doi/full/10.1056/NEJMe2034294 1 comment
- A Large, Simple Trial Leading to Complex Questions | NEJM https://www.nejm.org/doi/full/10.1056/NEJMe2034294?query=recirc_curatedRelated_article 1 comment
- Coronavirus Drug and Treatment Tracker - The New York Times https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.html 0 comments
- Hydroxychloroquine in Hospitalized Patients with Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2035374 0 comments
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2116846 0 comments
Linked pages
- Remdesivir for the Treatment of Covid-19 — Final Report | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2007764 55 comments
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2001282 16 comments
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2022926 8 comments
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2015301 6 comments
- A Large, Simple Trial Leading to Complex Questions | NEJM https://www.nejm.org/doi/full/10.1056/NEJMe2034294?query=recirc_curatedRelated_article 1 comment
- Dexamethasone in Hospitalized Patients with Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2021436?query=featured_home#.XxHPBggObHA.twitter 0 comments
Related searches:
Search whole site: site:doi.org
Search title: Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results | NEJM
See how to search.